Free Newsletter
Gates to increase spending despite heavy losses
Billionaire philanthropist Bill Gates says that the Bill & Melinda Gates Foundation lost about one fifth of its total value in last year's stock meltdown, but he plans to increase the amount of money he's spending on vaccine and other initiatives this year. In an open letter, the fulltime philanthropist promised to shell out $3.8 billion this year, seven percent of the foundation's wealth and a significant increase over the $3.3 billion spent last year.
Gates highlighted the foundation's success in helping advance a late-stage malaria vaccine, an ongoing effort on HIV/AIDS and an ambitiopus effort to rid the world of polio. But the Seattle Times notes that Gates billions have earned widespread criticism, as well. Scientists and others in the health field say that the Gates Foundation should be more open than it has been about its efforts and goals.
"I would hope he would expand it to be a two-way conversation, and to meet with folks, including grass-roots organizations," says Pablo Eisenberg, senior fellow at the Center for Public & Nonprofit Leadership at Georgetown University.
Gates says that is what the open letter is all about.
"Soon after Warren Buffett made his incredible gift, which doubled the resources of the foundation, he encouraged me to follow his lead by writing an annual letter," wrote Gates. "I won't be quoting Mae West or trying to match his humor, but I will try to be equally candid."
- read the report from the Seattle Times
- read the letter
Related Articles:
Donors pledge $635M to eradicate polio
Gates galvanizes anti-malaria campaign
Gates gives $168M for research into malaria vax
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: